Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,659	1,048	812.83	5,655	332.96
Short-Term Investments	4,165	5,971	6,960	2,392	7,473
Cash & Short-Term Investments	5,823	7,019	7,773	8,047	7,806
Cash Growth	-17.03%	-9.70%	-3.40%	3.08%	-6.14%
Accounts Receivable	46.81	18.34	25.77	13.08	14.59
Other Receivables	95.83	77.88	50.77	19.86	114.2
Receivables	142.64	96.22	76.54	32.95	128.79
Inventory	108.89	115.16	122.74	111.4	81.32
Other Current Assets	83.16	62.83	45.93	42.2	35.31
Total Current Assets	6,158	7,293	8,018	8,233	8,051
Property, Plant & Equipment	994.89	1,106	1,195	1,033	1,038
Long-Term Investments	3,146	3,737	4,096	3,920	3,871
Goodwill	57.44	57.44	89.14	89.14	89.14
Other Intangible Assets	933.83	1,125	1,682	2,010	2,388
Long-Term Accounts Receivable	11.42	-	-	-	32.41
Long-Term Deferred Tax Assets	238.82	137.57	79.21	97.46	62.85
Other Long-Term Assets	192.92	204.05	204.05	197.65	197.86
Total Assets	11,734	13,660	15,364	15,580	15,731
Accounts Payable	3.6	2.73	1.7	1.52	2.5
Accrued Expenses	415.18	103.57	119.05	155.39	78.16
Current Portion of Leases	42.96	41.18	34.25	13.25	12.73
Current Income Taxes Payable	0.87	0.12	0.12	12.69	35.1
Other Current Liabilities	58.8	35.32	60.24	25.76	28.75
Total Current Liabilities	521.42	182.92	215.36	208.6	157.24
Long-Term Leases	327.77	365.18	397.95	250.09	270.34
Long-Term Unearned Revenue	169.52	170.68	176.07	145.99	1,155
Long-Term Deferred Tax Liabilities	237.26	140.41	76.56	95.22	58.18
Other Long-Term Liabilities	0.47	0.47	0.48	0.48	0.48
Total Liabilities	1,256	859.65	866.43	700.38	1,642
Common Stock	4,802	4,791	4,545	3,910	3,853
Additional Paid-In Capital	6,515	7,623	9,050	8,637	9,469
Retained Earnings	-1,038	-1,154	-1,267	359.98	-1,036
Treasury Stock	-25.78	-25.78	-25.78	-25.78	-47.38
Comprehensive Income & Other	78.11	1,066	1,750	1,737	1,778
Total Common Equity	10,332	12,299	14,053	14,618	14,016
Minority Interest	145.45	501.02	444.07	262.28	72.95
Shareholders' Equity	10,477	12,800	14,497	14,880	14,089
Total Liabilities & Equity	11,734	13,660	15,364	15,580	15,731
Total Debt	370.73	406.35	432.2	263.34	283.07
Net Cash (Debt)	5,453	6,613	7,341	7,783	7,523
Net Cash Growth	-17.54%	-9.92%	-5.69%	3.46%	-6.13%
Net Cash Per Share	11.37	13.83	15.50	16.50	16.52
Filing Date Shares Outstanding	479.21	478.03	476.23	466.02	458.4
Total Common Shares Outstanding	479.21	478.03	476.23	466.02	458.4
Working Capital	5,637	7,110	7,803	8,025	7,894
Book Value Per Share	21.56	25.73	29.51	31.37	30.58
Tangible Book Value	9,340	11,117	12,282	12,519	11,539
Tangible Book Value Per Share	19.49	23.26	25.79	26.86	25.17
Buildings	640.6	640.27	637.35	602.54	580.99
Machinery	555.57	554.04	547.55	522.99	456.01
Construction In Progress	18.76	1.98	18.24	-	13.03
Leasehold Improvements	61.91	58.15	27.56	14.56	14.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.